| Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960) |
|---|
| 09/09/2011 | CA2787123A1 Rifaximin powder, process for preparing the same and controlled release compositions containing said rifaximin useful for obtaining a long-lasting effect |
| 09/08/2011 | US20110218195 Methods and compositions for treating bacterial infections and diseases associated therewith |
| 09/08/2011 | US20110217696 Aza-benzazolium containing cyanine dyes |
| 09/07/2011 | EP2227476B1 Tricyclic triazolic compounds |
| 09/07/2011 | EP2065388B1 Pyrazolopyrimidine derivative |
| 09/07/2011 | CN1582150B Staurosporine derivatives as inhibitors of FLT3 receptor tyrosine kinase activity |
| 09/07/2011 | CN102177153A Compositions and methods for treating alcohol use disorders, pain and other diseases |
| 09/07/2011 | CN102174053A Method for purifying everolimus |
| 09/07/2011 | CN102174042A Immunosuppressant compounds and compositions |
| 09/07/2011 | CN101048414B Fused tricyclic derivatives for the treatment of psychotic disorders |
| 09/06/2011 | US8012987 Indolo[2,1-b] quinazole-6,12-dione antimalarial compounds and methods of treating malaria therewith |
| 09/06/2011 | US8012960 Heterocyclic aspartyl protease inhibitors |
| 09/06/2011 | CA2469275C 1,8-annelated quinoline derivatives substituted with carbon-linked triazoles as farnesyl transferase inhibitors |
| 09/01/2011 | WO2011106445A1 Antiviral compounds |
| 09/01/2011 | WO2011106414A1 Inhibitors of beta-secretase |
| 09/01/2011 | WO2011106248A2 Trimethoxyphenyl inhibitors of tyrosine kinase |
| 09/01/2011 | WO2011104183A1 Novel microbicides |
| 09/01/2011 | US20110213152 Method for synthesis of 8-alkoxy-9h-isothiazolo[5,4-b]quinoline-3,4-diones |
| 09/01/2011 | US20110213147 New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents |
| 09/01/2011 | US20110213145 Compounds and Methods for Inhibiting the Interaction of BCL Proteins with Binding Partners |
| 09/01/2011 | US20110213143 Compound having tafia inhibitory activity |
| 09/01/2011 | US20110212942 Inhibitors of polo-like kinase |
| 09/01/2011 | US20110212938 Bicyclic heterocycle derivatives and their use as modulators of the activity of gpr119 |
| 09/01/2011 | US20110212920 N-Substituted Benzene Sulfonamides |
| 09/01/2011 | US20110212102 Heterocycloalkyl-containing thienopyrimidines for pharmaceutical compositions |
| 09/01/2011 | US20110212053 Phosphatidylinositol 3 kinase inhibitors |
| 09/01/2011 | CA2790199A1 Trimethoxyphenyl inhibitors of tyrosine kinase |
| 08/31/2011 | EP2361920A2 Preparation and use of carbohydrate-based ring structures with antimicrobial and cytostatic activity |
| 08/31/2011 | EP2361910A1 Compound having tafia inhibitory activity |
| 08/31/2011 | EP2361254A1 Raf inhibitors and their uses |
| 08/31/2011 | CN102171220A Pyrazolo [5, 1-b] oxazole derivatives as CRF1 antagonists |
| 08/31/2011 | CN102171219A Crystalline forms of a pyridine derivative |
| 08/31/2011 | CN101119968B Heterocyclic substituted phenyl methanones as inhibitors of the glycine transporter 1 |
| 08/30/2011 | US8008318 39-desmethoxy derivatives of rapamycin |
| 08/30/2011 | US8008293 Bicyclic oxomorpholine derivative |
| 08/30/2011 | US8008292 Condensed benzamide compounds and inhibitors of vanilloid receptor subtype 1 (VR1) activity |
| 08/25/2011 | WO2011103120A1 Forms of rifaximin and uses thereof |
| 08/25/2011 | WO2011103089A1 Crystalline forms of sodium 4-{[9-chloro-7-(2-fluoro-6--methoxyphenyl)-5h -pyrimido[5,4-d][2]benzazepin-2yl]amino}-2-methoxybenzoate |
| 08/25/2011 | WO2011101304A2 Piperidine derivatives |
| 08/25/2011 | US20110207725 CHIRAL FUSED [1,2]IMIDAZO[4,5-c] RING COMPOUNDS |
| 08/25/2011 | US20110207721 Purine derivatives as kinase inhibitors |
| 08/25/2011 | US20110207720 Quinolin-4-one and 4-oxodihyrdocinnoline derivatives as inhibitors of poly(adp-ribose) polymerase (parp) |
| 08/25/2011 | CA2790332A1 Forms of rifaximin and uses thereof |
| 08/25/2011 | CA2789058A1 Piperidine derivatives |
| 08/25/2011 | CA2788774A1 Crystalline forms of sodium 4-{[9-chloro-7-(2-fluoro-6-methoxyphenyl)-5h-pyrimido[5,4-d][2]benzazepin-2-yl]amino}-2-methoxybenzoate |
| 08/24/2011 | EP2360224A1 Photochromic compounds |
| 08/24/2011 | EP2360160A1 Intermediates and their use for producing benzoxazine derivative |
| 08/24/2011 | EP2360156A1 Method for manufacturing neuraminic acid derivatives |
| 08/24/2011 | EP2360151A1 Method for manufacturing neuraminic acid derivatives |
| 08/24/2011 | EP2360135A1 Method for manufacturing neuraminic acid derivatives |
| 08/24/2011 | CN102164927A Isoxazolo[4,5]pyridin-3-yl-piperazin derivatives useful as modulatorsof dopamine D3 receptors |
| 08/24/2011 | CN102161664A Photoreaction-based synthesis method of spiro isoquinoline polycyclic heterocyclic compounds |
| 08/23/2011 | US8003802 Total synthesis of Salinosporamide A and analogs thereof |
| 08/23/2011 | US8003634 Analogs of benzoquinone-containing ansamycins and methods of use thereof |
| 08/23/2011 | CA2489452C Phenylaminopyrimidines and their use as rho-kinase inhibitors |
| 08/18/2011 | WO2011100402A1 Macrocycles as factor xia inhibitors |
| 08/18/2011 | WO2011100401A1 Macrocycles as factor xia inhibitors |
| 08/18/2011 | WO2011100227A1 Benzylpyrrolidinone derivatives as modulators of chemokine receptor activity |
| 08/18/2011 | WO2011047320A3 Antimicrobial compounds and methods of making and using the same |
| 08/18/2011 | WO2010068181A8 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6)1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene citrate salt |
| 08/18/2011 | US20110201661 Spiro Derivatives of Parthenin as Novel Anticancer Agents |
| 08/18/2011 | US20110201629 Cyclohexyl amide derivatives as crf receptor antagonists |
| 08/18/2011 | US20110201605 Heteroaryl substituted piperidines |
| 08/18/2011 | US20110201577 Processes and intermediates for the preparation of oseltamivir and analogs thereof |
| 08/18/2011 | US20110198546 Photochromic material |
| 08/18/2011 | CA2789622A1 Macrocycles as factor xia inhibitors |
| 08/17/2011 | EP2357217A1 Photochromic compounds |
| 08/17/2011 | EP2357185A1 Naphthoxazine Benzoxazine-Based Monomer and Polymer Thereof |
| 08/17/2011 | EP2356125A1 Derivatives of oxabispidine as neuronal nicotinic acetylcholine receptor ligands |
| 08/17/2011 | EP2356124A1 Gamma secretase modulators |
| 08/17/2011 | EP2356115A1 Gamma secretase modulators |
| 08/17/2011 | EP2356109A2 Compositions and methods for treating alcohol use disorders, pain and other diseases |
| 08/17/2011 | EP2356106A1 Biaryl spiroaminooxazoline analogues as alpha2c adrenergic receptor modulators |
| 08/17/2011 | EP2167494B1 3-amino-6-(1-amino-ethyl)-tetrahydropyran derivatives |
| 08/17/2011 | EP1685137B1 Particle-forming compositions containing fused pyrrolocarbazoles |
| 08/17/2011 | CN102159582A Oxazolopyrimidines as edg-1 receptor agonists |
| 08/17/2011 | CN101643471B C3/C3 fluoroquinolone dimmer derivative using oxadiazole as connection chain as well as preparation method and application thereof |
| 08/16/2011 | US7998974 Fused heterocyclic compounds and their use as sirtuin modulators |
| 08/16/2011 | US7998951 treating hepatitis C infection; 6-cyclohexyl-2,3-dihydro-5-phenyl-1,4-oxazino[2,3,4-hi]indole-9-carboxylic acid |
| 08/16/2011 | US7998950 Antiviral compounds |
| 08/16/2011 | CA2629777C Spirocyclic compounds as hdac inhibitors |
| 08/11/2011 | US20110195986 Pyrrolone melanin concentrating hormone receptor-1 antagonists |
| 08/11/2011 | US20110195950 Organic Compounds |
| 08/11/2011 | US20110195408 Labeling Dye for Detecting Biomolecule, Labeling Kit, and Method for Detecting Biomolecule |
| 08/10/2011 | EP2353686A1 Method for purifying lactone compound having unsaturated alkyl group by extraction with silver ion solution |
| 08/10/2011 | EP2352731A1 Gamma secretase modulators |
| 08/10/2011 | EP2352730A2 Biologically active amides |
| 08/10/2011 | EP1751163B1 Benzazepine compounds having affinity for dopamine d3 receptor and uses thereof |
| 08/10/2011 | CN1129942B Aza spiro-compounds acting on the cholinergic system with muscarinic agonist activity |
| 08/10/2011 | CN102149697A 6-substituted benzoxazines as 5-HT-5A receptor antagonists |
| 08/10/2011 | CN102146087A Method for preparing high-purity levofloxacin semihydrate |
| 08/10/2011 | CN101648960B Method for preparing ofloxacin |
| 08/10/2011 | CN101619068B Novel method for preparing marbofloxacin |
| 08/09/2011 | US7994192 5-[3-(6,8-Dibromo-1,2,3,4-tetrahydro-quinolin-4-ylamino)-propylamino]-4H-thieno [3,2-b]pyridin-7-one, used as inhibitors of bacterial methionyl tRNA synthetase, administered for the treatment of bacterial infections; therapy for Clostridium difficile based infections |
| 08/04/2011 | WO2011093609A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 08/04/2011 | WO2011093529A1 Synthetic intermediate of oxazole compound and method for producing the same |
| 08/04/2011 | WO2011092564A2 Process for the preparation of temsirolimus and its intermediates |
| 08/04/2011 | WO2011092272A1 Gamma secretase modulaters |
| 08/04/2011 | WO2011092197A1 5-alkynyl pyrimidines and their use as kinase inhibitors |
| 08/04/2011 | US20110190486 Sulfonamide derivatives of polycyclic dyes used for analytical applications |